top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Asteroseismology and Exoplanets: Listening to the Stars and Searching for New Worlds : IVth Azores International Advanced School in Space Sciences / / edited by Tiago L. Campante, Nuno C. Santos, Mário J. P. F. G. Monteiro
Asteroseismology and Exoplanets: Listening to the Stars and Searching for New Worlds : IVth Azores International Advanced School in Space Sciences / / edited by Tiago L. Campante, Nuno C. Santos, Mário J. P. F. G. Monteiro
Edizione [1st ed. 2018.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018
Descrizione fisica 1 online resource (XVI, 282 p. 74 illus., 53 illus. in color.)
Disciplina 523.7
Collana Astrophysics and Space Science Proceedings
Soggetto topico Astronomy
Astronomy—Observations
Astrophysics
Space sciences
Astronomy, Observations and Techniques
Astrophysics and Astroparticles
Space Sciences (including Extraterrestrial Physics, Space Exploration and Astronautics)
ISBN 3-319-59315-3
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910300538403321
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Membrane-Peptide Interactions : From Basics to Current Applications
Membrane-Peptide Interactions : From Basics to Current Applications
Autore Santos Nuno C
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (302 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato accelerated molecular dynamics
ACE inhibitory peptides
alamethicin
amino acid sequence
anti-inflammatory peptide
anti-metastatic activity
anti-microbial peptides
antibiofilm
anticancer
antimicrobial
antimicrobial peptides
atomic force microscopy
bacterial membranes
biofilm
calcium hydroxide
CD spectroscopy
cell permeable peptide
cell-penetrating peptide
cell-penetrating peptides
chemokine
chionodracines
circular dichroism
circular dichroism spectroscopy
collagen-induced arthritis
critical aggregation concentration
cyclin F
cytotoxicity
drug-peptide conjugates
Enbrel
ESKAPE pathogens
feature selection
glucosylceramide (GlcCer)
heparin-binding peptide
host defense peptide
human beta defensin-3-C15
human dental pulp cell
inducible nitric oxide
interferon gamma
interleukin-6
KR12
Langmuir monolayer
lipid model systems
lipopeptide
liposomes
LL-37
luffa sponge
machine learning
mass spectrometry
Matrix-assisted laser desorption ionization
melittin
membrane
membrane affinity
membrane biophysics
metastasis model of B16F10 melanoma
model membranes
molecular docking
molecular dynamics
mycolic acid
NMR
non-lytic peptides
nuclear magnetic resonance solution structure
organisms
peptaibol
peptide-lipid interaction
peptide-lipid interactions
peptide-membrane interaction
phosphopeptide
Pisum sativum defensin 1 (Psd1)
pore-forming peptides
sequence analysis
sesame protein
simulated gastrointestinal digestion
solid-phase extraction
Staphylococcus aureus
Streptococcus gordonii lipoprotein
structure-activity
surface plasmon resonance
tachyplesin
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Membrane–Peptide Interactions
Membrane–Peptide Interactions
Record Nr. UNINA-9910557551603321
Santos Nuno C  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Peptide drug discovery and development [[electronic resource] ] : translational research in academia and industry / / edited by Miguel Castanho and Nuno C. Santos
Peptide drug discovery and development [[electronic resource] ] : translational research in academia and industry / / edited by Miguel Castanho and Nuno C. Santos
Pubbl/distr/stampa Weinheim, Germany, : Wiley-VCH, 2011
Descrizione fisica 1 online resource (392 p.)
Disciplina 572.65
615.19
Altri autori (Persone) CastanhoMiguel
SantosNuno C
Soggetto topico Peptide drugs
Drugs - Design
Pharmacology
ISBN 3-527-63674-9
1-283-30251-9
9786613302519
3-527-63673-0
3-527-63675-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Peptide Drug Discovery and Development: Translational Research in Academia and Industry; Contents; Preface; List of Contributors; Part I: The Academia - Market Bouncing of Peptide Drugs - Challenges and Strategies in Translational Research with Peptide Drugs; 1: Peptides as Leads for Drug Discovery; 1.1: Introduction; 1.2: Overview of Process for Transforming Peptides to Peptidomimetics; 1.3: HCMV Protease; 1.3.1: HCMV Protease: Identification and Characterization of Antiviral Inhibitors Targeting the Serine Protease Domain of the Human Cytomegalovirus (HCMV Protease)
1.3.2: Mapping Essential Elements of the Substrate Peptides and Determining Structures of Ligands Bound to HCMV1.3.3: Improving Peptide Activity to Allow SAR Studies; 1.3.4: Elucidation of the Binding Mode of the Optimized Peptidyl Segment; 1.3.5: Ligand Adaptations upon Binding; 1.3.6: Strategic Summary for HCMV Peptide Mimic Design Process; 1.4: HCV Protease; 1.4.1: HCV Protease as an Antiviral Target; 1.4.2: NS3 Serine Protease Possesses a Chymotrypsin-Like Fold; 1.4.3: Discovery of the Peptide DDIVPC as an Inhibitor of NS3 Protease
1.4.4: ''Sensemaking'' and Knowledge Building: Mapping of the Critical Binding Residues of the Peptide and Creation of an Inhibitor-Protease Model1.4.5: Knowledge Building: Monitoring Ligand Flexibility in the Free-State and Changes Upon Binding - P3 Rigidification; 1.4.6: N-Terminal Truncation and Improved P1, P2 and P5 Substituents; 1.4.7: Macrocyclization: Linking the Flexible P1 Side-Chain to P3; 1.4.8: HCV Protease Inhibitor BI00201335; 1.5: Herpes Simplex Virus; 1.5.1: Herpes Simplex Virus-Encoded Ribonucleotide Reductase Inhibitors; 1.6: Renin
1.6.1: Aspartyl Protease Renin as a Target1.7: HIV; 1.7.1: HIV Protease Inhibitors; 1.8: Conclusions; 2: Marketing Antimicrobial Peptides: A Critical Academic Point of View; 2.1: Introduction; 2.2: Basic Research: Antimicrobial Peptides; 2.3: Patents; 2.4: Potential Applications of AMPs; 2.5: Technology Transfer: Valorization, Licensing, or Spin-Off Creation; 2.6: Spin-Off Creation: An Academic Point of View; 3: Oral Peptide Drug Delivery: Strategies to Overcome Challenges; 3.1: Introduction; 3.2: Challenges Associated with Oral Peptide Delivery
3.2.1: Transport Pathways Across the Intestinal Epithelium3.2.2: Unfavorable Physicochemical Properties of Peptide Drugs; 3.2.2.1: Molecular Size, Hydrophilicity, and Physical Stability; 3.2.3: Physical Barriers of the Gastrointestinal Tract; 3.2.3.1: Transcellular Pathway; 3.2.3.2: Paracellular Pathway; 3.2.4: Biochemical Barriers of the Gastrointestinal Tract; 3.2.4.1: Luminal Enzymes; 3.2.4.2: Brush Border Membrane Bound Enzymes and Intracellular Enzymes; 3.2.5: Efflux Transport Systems; 3.2.6: Gastrointestinal Transit Time and Site-Specific Absorption
3.3: Strategies to Overcome the Barriers of the Gastrointestinal Tract
Record Nr. UNINA-9910139579303321
Weinheim, Germany, : Wiley-VCH, 2011
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Peptide drug discovery and development : translational research in academia and industry / / edited by Miguel Castanho and Nuno C. Santos
Peptide drug discovery and development : translational research in academia and industry / / edited by Miguel Castanho and Nuno C. Santos
Edizione [1st ed.]
Pubbl/distr/stampa Weinheim, Germany, : Wiley-VCH, 2011
Descrizione fisica 1 online resource (xix, 370 pages) : illustrations
Disciplina 572.65
615.19
Altri autori (Persone) CastanhoMiguel
SantosNuno C
Soggetto topico Peptide drugs
Drugs - Design
Pharmacology
ISBN 9786613302519
9783527636747
3527636749
9781283302517
1283302519
9783527636730
3527636730
9783527636754
3527636757
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Peptide Drug Discovery and Development: Translational Research in Academia and Industry; Contents; Preface; List of Contributors; Part I: The Academia - Market Bouncing of Peptide Drugs - Challenges and Strategies in Translational Research with Peptide Drugs; 1: Peptides as Leads for Drug Discovery; 1.1: Introduction; 1.2: Overview of Process for Transforming Peptides to Peptidomimetics; 1.3: HCMV Protease; 1.3.1: HCMV Protease: Identification and Characterization of Antiviral Inhibitors Targeting the Serine Protease Domain of the Human Cytomegalovirus (HCMV Protease)
1.3.2: Mapping Essential Elements of the Substrate Peptides and Determining Structures of Ligands Bound to HCMV1.3.3: Improving Peptide Activity to Allow SAR Studies; 1.3.4: Elucidation of the Binding Mode of the Optimized Peptidyl Segment; 1.3.5: Ligand Adaptations upon Binding; 1.3.6: Strategic Summary for HCMV Peptide Mimic Design Process; 1.4: HCV Protease; 1.4.1: HCV Protease as an Antiviral Target; 1.4.2: NS3 Serine Protease Possesses a Chymotrypsin-Like Fold; 1.4.3: Discovery of the Peptide DDIVPC as an Inhibitor of NS3 Protease
1.4.4: ''Sensemaking'' and Knowledge Building: Mapping of the Critical Binding Residues of the Peptide and Creation of an Inhibitor-Protease Model1.4.5: Knowledge Building: Monitoring Ligand Flexibility in the Free-State and Changes Upon Binding - P3 Rigidification; 1.4.6: N-Terminal Truncation and Improved P1, P2 and P5 Substituents; 1.4.7: Macrocyclization: Linking the Flexible P1 Side-Chain to P3; 1.4.8: HCV Protease Inhibitor BI00201335; 1.5: Herpes Simplex Virus; 1.5.1: Herpes Simplex Virus-Encoded Ribonucleotide Reductase Inhibitors; 1.6: Renin
1.6.1: Aspartyl Protease Renin as a Target1.7: HIV; 1.7.1: HIV Protease Inhibitors; 1.8: Conclusions; 2: Marketing Antimicrobial Peptides: A Critical Academic Point of View; 2.1: Introduction; 2.2: Basic Research: Antimicrobial Peptides; 2.3: Patents; 2.4: Potential Applications of AMPs; 2.5: Technology Transfer: Valorization, Licensing, or Spin-Off Creation; 2.6: Spin-Off Creation: An Academic Point of View; 3: Oral Peptide Drug Delivery: Strategies to Overcome Challenges; 3.1: Introduction; 3.2: Challenges Associated with Oral Peptide Delivery
3.2.1: Transport Pathways Across the Intestinal Epithelium3.2.2: Unfavorable Physicochemical Properties of Peptide Drugs; 3.2.2.1: Molecular Size, Hydrophilicity, and Physical Stability; 3.2.3: Physical Barriers of the Gastrointestinal Tract; 3.2.3.1: Transcellular Pathway; 3.2.3.2: Paracellular Pathway; 3.2.4: Biochemical Barriers of the Gastrointestinal Tract; 3.2.4.1: Luminal Enzymes; 3.2.4.2: Brush Border Membrane Bound Enzymes and Intracellular Enzymes; 3.2.5: Efflux Transport Systems; 3.2.6: Gastrointestinal Transit Time and Site-Specific Absorption; 3.3: Strategies to Overcome the Barriers of the Gastrointestinal Tract
Record Nr. UNINA-9910829074503321
Weinheim, Germany, : Wiley-VCH, 2011
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui